Blue Trust’s Medline MDLN Stock Holding History
Bought
Maintained
Sold
Other funds holding MDLN
Blue Trust's MDLN Position: Q3 2026 in Review
Blue Trust reduced its Medline (MDLN) stake by 20% in Q3 2026, selling an estimated $1.35K and leaving 150 shares worth $5.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.
Blue Trust first reported a position in MDLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $7.38K in Q2 2026. 331 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.
- Blue Trust held 150 shares of Medline worth $5.2K as of Q3 2026.
- Blue Trust sold 37 Medline shares in Q3 2026, an estimated $1.35K.
- Medline made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1844 holding.
- Blue Trust first reported a position in Medline in Q2 2026 and has held it in 2 quarters since.
- Blue Trust's Medline position peaked at $7.38K in Q2 2026.
- 331 funds tracked by Wall St. Rank held Medline as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.